CD8A and neoplasm: Intratumorally, PMN-MDSCs to CD8+T ratios were also significantly reduced in the tumor-bearing mice that received the combination therapy while hetIL-15 decreased only the PMN-MDSCs to NKs ratios (Supplementary Figure S5E).